Your browser doesn't support javascript.
loading
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network.
De Rycke, Ophélie; Perrier, Marine; Ouvrard, Éric; Mennetrey, Clément; Lachachi, Choaib; Bando-Delaunay, Aurélie; Morland, David; Goichot, Bernard; Taieb, David; Walter, Thomas; Cadiot, Guillaume; Cros, Jérôme; Hentic, Olivia; Ruszniewski, Philippe; Lebtahi, Rachida; Imperiale, Alessio; de Mestier, Louis.
Afiliação
  • De Rycke O; Department of Pancreatology and Digestive Oncology, Beaujon Hospital, Université Paris-Cité, AP-HP.Nord, Clichy, France.
  • Perrier M; INSERM UMR 1149, Centre de Recherche sur l'Inflammation, Paris, France.
  • Ouvrard É; Department of Hepato-Gastroenterology and Digestive Oncology, CHU Reims, Université de Reims Champagne-Ardenne, Reims, France.
  • Mennetrey C; Department of Nuclear Medicine, Hautepierre University Hospital, Strasbourg, France.
  • Lachachi C; Department of Nuclear Medicine, La Timone University Hospital, Université d'Aix-Marseille, Marseille, France.
  • Bando-Delaunay A; Department of Nuclear Medicine, Edouard-Herriot University Hospital, Lyon, France.
  • Morland D; INSERM UMR 1149, Centre de Recherche sur l'Inflammation, Paris, France.
  • Goichot B; Department of Nuclear Medicine, Beaujon Hospital, Université Paris-Cité, AP-HP.Nord, Clichy, France.
  • Taieb D; Department of Nuclear Medicine, Institut Godinot, Reims, France.
  • Walter T; Université de Reims Champagne Ardenne, CReSTIC, EA 3804, Reims, France.
  • Cadiot G; Department of Endocrinology, Hautepierre University Hospital, Strasbourg, France.
  • Cros J; Department of Nuclear Medicine, La Timone University Hospital, Université d'Aix-Marseille, Marseille, France.
  • Hentic O; Department of Digestive Oncology, Edouard-Herriot University Hospital, Lyon, France; and.
  • Ruszniewski P; Department of Hepato-Gastroenterology and Digestive Oncology, CHU Reims, Université de Reims Champagne-Ardenne, Reims, France.
  • Lebtahi R; INSERM UMR 1149, Centre de Recherche sur l'Inflammation, Paris, France.
  • Imperiale A; Department of Pathology, Beaujon Hospital, AP-HP.Nord, Université Paris-Cité, Clichy, France.
  • de Mestier L; Department of Pancreatology and Digestive Oncology, Beaujon Hospital, Université Paris-Cité, AP-HP.Nord, Clichy, France.
J Nucl Med ; 64(11): 1699-1705, 2023 11.
Article em En | MEDLINE | ID: mdl-37652547

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article